TTD | Drug: D0FF0Z

Drug General Information
Drug ID	D0FF0Z
Former ID	DNC008912
Drug Name	4-(3-Phenylethynyl-benzyl)-1H-imidazole
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529437]
Structure		Download 2D MOL 3D MOL
Formula	C18H14N2
Canonical SMILES	C1=CC=C(C=C1)C#CC2=CC(=CC=C2)CC3=CN=CN3
InChI	1S/C18H14N2/c1-2-5-15(6-3-1)9-10-16-7-4-8-17(11-16)12-18-13-19-14-20-18/h1-8,11,13-14H,12H2,(H,19,20)
InChIKey	VIPAIZRIFZFESY-UHFFFAOYSA-N
PubChem Compound ID	24825516
Target and Pathway
Target(s)	Cytochrome P450 2D6	Target Info	Inhibitor	[529437]
KEGG Pathway	Metabolism of xenobiotics by cytochrome P450
	Drug metabolism - cytochrome P450
	Serotonergic synapse
Reactome	Xenobiotics
WikiPathways	Metapathway biotransformation
	Tamoxifen metabolism
	Oxidation by Cytochrome P450
	Vitamin D Receptor Pathway
	Aripiprazole Metabolic Pathway
	Fatty Acid Omega Oxidation
	Codeine and Morphine Metabolism
References
Ref 529437	J Med Chem. 2008 May 22;51(10):2944-53. Epub 2008 Apr 24.4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
Ref 529437	J Med Chem. 2008 May 22;51(10):2944-53. Epub 2008 Apr 24.4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information